The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies

Latanoprostene bunod (LBN) is a topical ophthalmic therapeutic for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (OHT). LBN is composed of latanoprost acid (LA) linked to a nitric oxide (NO)-donating moiety and is the first NO-releasing prost...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavet, Megan E., DeCory, Heleen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Volume 1: Glaucoma IOP, Neuroprotection and Devices
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963638/
https://www.ncbi.nlm.nih.gov/pubmed/28783422
http://dx.doi.org/10.1089/jop.2016.0188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963638/
https://www.ncbi.nlm.nih.gov/pubmed/28783422
http://dx.doi.org/10.1089/jop.2016.0188

Ejemplares similares